A mechanistic study on the cardiotoxicity of 5-fluorouracil in vitro and clinical and occupational perspectives

作者：Lamberti Monica^*; Porto Stefania; Zappavigna Silvia; Addeo Erasmo; Marra Monica; Miraglia Nadia; Sannolo Nicola; Vanacore Daniela; Stiuso Paola; CaragliabaSectio Michele

来源：Toxicology Letters, 2014, 227(3): 151-156.

DOI：10.1016/j.toxlet.2014.03.018

• 5-Fluorouracil
• Cardiotoxicity
• Rat cardiocytes model
• Occupational health

Fluoropyrimidines are key agents for the treatment of gastrointestinal tract adenocarcinomas. The possible cardiotoxic effects in patients and occupationally exposed workers are multifactorial and remain a puzzle to solve for investigators. In the present study, we study what cell death pathways and what doses can determine direct cardiotoxic effects of 5-fluorouracil (5-FU) and doxorubicin (DOXO) on rat cardiocytes (H9c2) and a human colon adenocarcinoma (HT-29) cell line, already reported to be sensitive to 5-FU. We have found that 5-FU induced 50% growth inhibition (IC:50) at 72h with concentrations of 400 mu M and 4 mu M on H9c2 and HT-29, respectively. Moreover, we have found that the addition of Levofolinic Acid (LF) to 5-FU potentiated the growth inhibition induced by 5-FU. The growth inhibition induced by 5-FU alone or in combination with LF in cardiocytes was paralleled by an increase of thiobarbituric acid-reactive species (Tbars) and end products of nitric oxide (NO) suggesting the increase of the oxidative stress status in cardiocytes. Interestingly, these effects were strongly potentiated by the addition of LF, a biochemical modulator of 5-FU activity. %26lt;br%26gt;Our data suggest that agents such as 5-FU different from anthracyclines, conventionally related to the induction of cardiotoxic effects, can also induce cardiocyte damage paralleled by oxidative stress. The strategies based upon the use of scavengers could be used in order to prevent this effect.

• 出版日期2014-6-16